Stress-Testing Dose Recommendations Against Assumptions

Why Stress-Test a Dose Recommendation?

A dose recommendation is supported by evidence interpreted through assumptions: a chosen dose-response model, an endpoint definition, a rule for handling missing outcomes, and decisions about which studies to include. A recommendation can appear clear under the primary analysis yet change when one of these assumptions changes. Stress-testing makes that dependence visible before a recommendation is treated as robust.

The purpose is not to try many analyses and select the one that gives the preferred answer. Instead, define a small set of scientifically plausible alternatives, recalculate the relevant dose comparisons under each, and report whether the decision changes. The earlier material on dose-response interpretation and dose selection supplies the clinical context: statistical differences alone do not establish that one dose is meaningfully better or acceptably safe.

A useful starting point is to state the decision rule in clinical terms. For example, a dose might need to exceed a minimum efficacy threshold while remaining below a safety limit. Keep that rule fixed while testing assumptions; otherwise, a changed result could be due to the rule rather than the evidence model. If the rule itself is uncertain, that is a separate sensitivity question and should be identified as such.

Changing the Dose-Response Model

A model form determines how observed dose-response information is translated into predictions at candidate doses. A linear model assumes a constant change in response per unit increase in dose over the modeled range. A saturating model allows the response to approach a maximum, so that the incremental gain tends to shrink as dose rises. Neither form is automatically correct; the data, scientific plausibility, and range of doses matter.

A model comparison should examine more than which fitted curve looks smoother. Check whether each form adequately describes the observed pattern, whether its parameters are estimated with useful precision, and whether the decision depends on predictions outside the observed dose range. A flexible model can follow noise; a simple model can miss curvature. When the ranking changes, the appropriate conclusion is that the recommendation is model-sensitive—not that whichever model predicts the desired dose should be preferred.

Endpoint Definitions Can Change the Ranking

A dose ranking is always a ranking for a particular endpoint and analysis population. A continuous change score and a responder endpoint can order doses differently because they answer different questions. A responder definition also depends on a threshold: changing the threshold can change which patients count as responders, even when the underlying measurements are unchanged. Therefore, endpoint sensitivity should compare clinically meaningful, defensible definitions, not thresholds chosen after seeing which one favors a dose.

Missing Outcomes and Study Influence

Missing-data assumptions matter when the probability of an unobserved outcome is related to treatment, observed information, or the unobserved outcome itself. A complete-case analysis describes patients with observed outcomes and may not represent all randomized patients. A nonresponder-imputation analysis treats missing outcomes as failures for a responder endpoint. A missing-at-random analysis instead relies on the assumption that, conditional on included observed information, missingness does not depend on the unobserved outcome. These assumptions are not interchangeable, and none can be verified from the observed data alone.

A study can also exert disproportionate influence on a pooled estimate. For independent study estimates with known standard errors, the inverse-variance weighted mean is the estimate-weighted average using weights equal to the inverse variances. The following derivation explains why a study with a small standard error receives greater weight.

To justify the formula, assume \(\hat{\theta}_i\) are independent normally distributed estimates of a common effect \(\theta\), with variances \(SE_i^2\). Their log likelihood, apart from constants, is \(-\frac{1}{2}\sum_i(\hat{\theta}_i-\theta)^2/SE_i^2\). Differentiating with respect to \(\theta\) and setting the derivative to zero gives \(\sum_i(\hat{\theta}_i-\theta)/SE_i^2=0\). Rearranging yields the weighted-mean formula above. The common-effect and independence assumptions are important: if studies estimate different underlying effects, this calculation may not be an adequate pooling model.

Interpreting Results and Diagnosing Fragility

For every stress test, record the baseline assumption, the alternative, the recalculated result, and whether the decision changes. Also check whether the comparison is being made on the same endpoint, dose range, population, and decision criteria. A changed estimate is not necessarily a changed decision; conversely, a small change can matter if it moves a dose across a clinical or safety threshold.

Useful diagnostics include residual patterns and poor fit for a dose-response model; sparse data near a predicted threshold; excessive sensitivity to a responder cutoff; substantial or imbalanced missingness; and large changes when a study is removed. Also inspect whether predictions rely on extrapolation, whether one study has unusually high weight, and whether its results differ for a known clinical or design reason. These signals do not automatically invalidate an analysis, but they identify where a recommendation needs qualification or further evidence.

Alternative approaches answer related but different questions. A primary analysis estimates effects under its chosen assumptions; a sensitivity analysis checks how conclusions vary under alternatives. Model averaging can represent uncertainty across several dose-response forms, but requires a defensible set of models and a way to combine them. A random-effects meta-analysis allows study effects to vary, unlike the common-effect calculation illustrated above, but it does not make influential studies or missing-data assumptions irrelevant. These methods complement, rather than replace, transparent stress tests.

Stress tests have limits. A stable ranking across a few alternatives does not prove that all important assumptions are correct. Conversely, instability may reflect sparse evidence or endpoints that capture distinct clinical features rather than a defective analysis. Avoid selecting assumptions after observing which dose they favor, treating a nonsignificant contrast as proof of equality, or interpreting a sensitivity analysis as independent confirmation. The practical outcome is a calibrated statement: which dose is favored, under which assumptions, and how easily that conclusion changes.